Within the partnership Fidelis will be able to utilize the resources of Sofia Tech Park’s “In vitro” laboratory for evaluation of biological activity and toxicity facilities to process biological samples procured by Fidelis, isolate primary cultures and develop cell lines for medical research.
The collaboration will greatly enhance the company’s service offering, strengthening Fidelis’ capabilities to conduct own research on new molecules and biomarkers both in-house and in partnership with its clients.
Fidelis is dedicated to accelerating research and providing value to its clients by enabling reduced development time and R&D costs. Thanks to the newly established partnership Fidelis will enable the development of companion diagnostics bound to be an integral part of the ever more relevant field of personalized medicine.
For further information on available products and services provided by Fidelis, please contact firstname.lastname@example.org. To read more about STP’s lab complex, head to http://sofiatech.bg/en/about/tin/laboratory-complex/invitro/